Amicus Therapeutics, Inc.
FOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56 | -$152 | -$237 | -$250 |
| Dep. & Amort. | $9 | $8 | $5 | $6 |
| Deferred Tax | $0 | -$5 | $0 | $0 |
| Stock-Based Comp. | $85 | $86 | $77 | $58 |
| Change in WC | -$99 | -$48 | -$40 | -$19 |
| Other Non-Cash | $28 | $41 | $28 | $2 |
| Operating Cash Flow | -$34 | -$69 | -$167 | -$202 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$7 | -$4 | -$4 |
| Net Acquisitions | $0 | $0 | $3 | $0 |
| Inv. Purchases | -$115 | -$92 | -$243 | -$341 |
| Inv. Sales/Matur. | $118 | $197 | $336 | $424 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | $98 | $92 | $79 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$21 | -$0 | -$0 |
| Stock Issued | $27 | $93 | $4 | $200 |
| Stock Repurch. | $0 | $0 | -$11 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$22 | -$10 | $0 | $13 |
| Financing Cash Flow | $5 | $62 | -$7 | $212 |
| Forex Effect | -$4 | $6 | -$15 | -$5 |
| Net Chg. in Cash | -$33 | $97 | -$96 | $83 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $250 | $153 | $249 | $166 |
| End Cash | $217 | $250 | $153 | $249 |
| Free Cash Flow | -$37 | -$77 | -$170 | -$206 |